✦ LIBER ✦

Influence of study sponsorship on head and neck cancer randomized trial results

✍ Scribed by Gordon H. Sun; Jeffrey J. Houlton; Mark P. MacEachern; Carol R. Bradford; Rodney A. Hayward

Book ID: 115556246
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 102 KB
Volume: aop
Category: Article
ISSN: 1043-3074
DOI: 10.1002/hed.23151

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction chemotherapy in advanced head

Induction chemotherapy in advanced head and neck tumors: Results of two randomized trials

✍ C. Jaulerry; J. Rodriguez; F. Brunin; M. Jouve; V. Mosseri; D. Point; D. Pontver 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 829 KB

Chemoradiotherapy for advanced head and

Chemoradiotherapy for advanced head and neck cancer — Analysis of a prospective, randomized trial

✍ D. Mitra; S. Basu; A. R. Deb; M. A. Rashid; P. K. Sur 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 597 KB

Randomized Phase III Trial of Postoperat

Randomized Phase III Trial of Postoperative Radiochemotherapy ± Amifostine in Head and Neck Cancer

✍ Peter Vacha,Fabian Fehlauer,Birgit Mahlmann… 📂 Article 📅 2003 🏛 Springer 🌐 German ⚖ 94 KB

Intra-arterial versus intravenous chemor

Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer: Results of a randomized phase 3 trial

✍ Coen R. N. Rasch; Michael Hauptmann; Jan Schornagel; Oda Wijers; Jan Buter; Theo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 1 views

A report on misonidazole in a randomized

A report on misonidazole in a randomized trial in locally advanced head and neck cancer

✍ R. Sealy; A. Williams; S. Cridland; M. Stratford; A. Minchinton; C. Hallet 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 398 KB

Induction chemotherapy in head and neck

Induction chemotherapy in head and neck cancer: Results of a phase III trial

✍ Dr. Jean-Jacques Mazeron; Michel Martin; Bernard Brun; Laval Grimard; Gilles Lel 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 661 KB

stage 11-Ill-IV squamous cell carcinoma of the oropharynx or oral cavity were randomized to induction chemotherapy, consisting of bleomycin (10 mg/m\*/day in continuous infusion from day 1 to day 5), methotrexate (120 mg/m2 on day 2) followed by folink acid, 5-fluorouracil (5 FU) (600 mg/m2 on day 2